SLC10A1 and liver disorder: With recent structural elucidation of NTCP, (Goutam et al., 2022) new insights into the interaction of NTCP with mTOR inhibitors can be investigated and the underlying mechanisms of NTCP transport and inhibition could be leveraged to develop novel inhibitors for the treatment of liver diseases.